Corneal Langerhans cell and dry eye examinations in ankylosing spondylitis

APCs of the ocular surface, including corneal Langerhans cells (LCs), offer the opportunity to gain insight into the activity of innate immunity. We examined corneal LCs and dry eye parameters in ankylosing spondylitis (AS). Twenty-four AS patients with varying degrees of disease activity and 24 healthy participants were enrolled. Central and peripheral LC numbers, and Langerhans cell morphology (LCM) were assessed with in vivo laser confocal microscopy. In addition, ocular surface disease index, lid parallel conjunctival folds, tear break up time, and Schirmer test were evaluated. LC densities and central LCM were greater in AS patients than in the controls. Moreover, LCM was significantly greater in patients with higher systemic inflammation according to elevated C-reactive protein (CRP). Also, tear production was greatly suppressed in patients with more severe onset of the systemic inflammation according to the Bath Ankylosing Spondylitis Disease Activity Index and elevated CRP. Greater corneal LC density and LCM in AS may reflect an increased activation state of the innate immune system of the cornea in AS, which correlates with the systemic activity of AS even without ocular symptoms. Nonetheless, higher systemic inflammation might impair tear production, and it might partly explain the dry eye mechanism.

[1]  L. Kovács,et al.  In vivo confocal microscopic evaluation of corneal Langerhans cell density, and distribution and evaluation of dry eye in rheumatoid arthritis , 2013, Innate immunity.

[2]  D. Galimberti,et al.  Inflammation in dry eye associated with rheumatoid arthritis: Cytokine and in vivo confocal microscopy study , 2013, Innate immunity.

[3]  A. Samanta,et al.  Update on biologic therapies in ankylosing spondylitis: a literature review , 2012, International journal of rheumatic diseases.

[4]  J. Németh,et al.  Lid-parallel conjunctival folds (LIPCOF) and dry eye: a multicentre study , 2012, British Journal of Ophthalmology.

[5]  I. E. van der Horst-Bruinsma,et al.  Management and evaluation of extra-articular manifestations in spondyloarthritis , 2012, Therapeutic advances in musculoskeletal disease.

[6]  L. Wheeler,et al.  Ocular Surface APCs Are Necessary for Autoreactive T Cell-Mediated Experimental Autoimmune Lacrimal Keratoconjunctivitis , 2011, The Journal of Immunology.

[7]  N. Pfeiffer,et al.  Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. , 2011, Investigative ophthalmology & visual science.

[8]  D. Galimberti,et al.  In vivo confocal microscopy of conjunctival roundish bright objects: young, older, and Sjögren subjects. , 2011, Investigative ophthalmology & visual science.

[9]  L. Carmona,et al.  Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis. , 2011, Seminars in arthritis and rheumatism.

[10]  P. Murphy,et al.  The relationship between clinical signs and dry eye symptoms , 2011, Eye.

[11]  P. Beck‐Peccoz,et al.  Corneal involvement in Graves' orbitopathy: an in vivo confocal study. , 2010, Investigative ophthalmology & visual science.

[12]  T. Yoshitomi,et al.  Cauterization of Central Cornea Induces Recruitment of Major Histocompatibility Complex Class II+ Langerhans Cells From Limbal Basal Epithelium , 2010, Cornea.

[13]  Yi Wei,et al.  Analysis of Inflammatory Cytokines in the Tears of Dry Eye Patients , 2009, Cornea.

[14]  K. Tsubota,et al.  Evaluation of conjunctival inflammatory status by confocal scanning laser microscopy and conjunctival brush cytology in patients with atopic keratoconjunctivitis (AKC) , 2009, Molecular vision.

[15]  William Farley,et al.  Tear cytokine profiles in dysfunctional tear syndrome. , 2009, American journal of ophthalmology.

[16]  Muhammad Asim Khan,et al.  HLA-B27 and its pathogenic role. , 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[17]  D. Galimberti,et al.  Corneal involvement in rheumatoid arthritis: an in vivo confocal study. , 2008, Investigative ophthalmology & visual science.

[18]  E. Doğanavşargil,et al.  Sjögren’s syndrome in patients with ankylosing spondylitis , 2006, Clinical Rheumatology.

[19]  B. Vollmar,et al.  In vivo confocal microscopic evaluation of Langerhans cell density and distribution in the normal human corneal epithelium , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[20]  R. Linder,et al.  Prevalence of the spondyloarthritides in patients with uveitis. , 2004, The Journal of rheumatology.

[21]  M. Dougados,et al.  Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. , 2004, Ophthalmology.

[22]  M. Dana,et al.  Corneal immunity is mediated by heterogeneous population of antigen‐presenting cells , 2003, Journal of leukocyte biology.

[23]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[24]  D. Weeks,et al.  Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. , 2001, American journal of human genetics.

[25]  A. Calin,et al.  A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. , 1994, The Journal of rheumatology.

[26]  A. Cats,et al.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.

[27]  W. Braun,et al.  Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis. , 1977, Arthritis and rheumatism.

[28]  E. L. Persons,et al.  Ankylosing Spondylitis , 1955, GP.

[29]  Zuguo Liu,et al.  Changes in corneal epithelial layer inflammatory cells in aqueous tear-deficient dry eye. , 2010, Investigative ophthalmology & visual science.

[30]  K. Tsubota,et al.  Conjunctival in vivo confocal scanning laser microscopy in patients with Sjögren syndrome. , 2010, Investigative ophthalmology & visual science.

[31]  R. Dana,et al.  Corneal antigen-presenting cells. , 2007, Chemical immunology and allergy.

[32]  W. Streilein,et al.  Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege. , 1998, Investigative ophthalmology & visual science.